CONTROLLED SUBSTANCE WASTE IN HOME HOSPICE SETTINGS

Author(s)

Terri Maxwell, PhD, APRN, BCPCM, VP of Research1, Catherine J Woods, JD, Associate Counsel & Sr. Director, Regulatory Affairs1, Kate Steward, BA, Policy & Regulatory Compliance Coordinator1, Megan Knowlton, BA, Legal Research Assistant1, Deborah Liao, BA, PharmD, Outcomes Research Fellow21excelleRx, Inc, Philadelphia, PA, USA; 2 Jefferson Medical College, Philadelphia, PA, USA

Objective: To describe the amount and types of unused controlled substances (CS) at the time of death in home hospice and to describe methods used by hospice nurses to destroy CS after patients expire. Methods: Retrospective chart review of 105 home hospice patients with a narcotic waste destruction record who expired during a 3-month period in 2007 while receiving care from 4 small hospices (average daily census [ADC] <60) and 1 large (ADC = 160) hospice in the Southeastern Pennsylvania region. Data were collected through review of narcotic waste destruction records as recorded by nurses at the time of patient death. Strength of formulation was recorded sporadically. Hospice nurses were surveyed about CS disposal methods. Results: Mean age of the patients was 78, (range 44-103); majority (57%) was diagnosed with cancer, followed by heart failure (24%). Average length of stay in hospice was 42 days (median 21). Almost all patients had unused CS; morphine concentrate (20mg/ml) was the most common medication (average 31.8 ml./patient). Collectively, over 3 liters (64,680 mg) of morphine were destroyed. Lorazepam was the next most common drug with 990 tablets and 397 ml liquid wasted. Other CS remaining at the time of death included varying strengths of long-acting morphine (251 tablets); OxyContin (90 tablets); and unused transdermal fentanyl (57 patches). Hospice nurses disposed of all unused CS by flushing them down the toilet. Conclusion: Although not excessive on an individual level, the amount of CS waste in hospice is significant when viewed in the aggregate. When flushed, these medications reach water ways, potentially posing environmental or health hazards. Regulatory changes are required to address disposal of unused CS. Future analyses should examine the cost of CS medication waste in hospice.

Conference/Value in Health Info

2008-05, ISPOR 2008, Toronto, Ontario, Canada

Value in Health, Vol. 11, No. 3 (May/June 2008)

Code

PHP13

Topic

Health Policy & Regulatory

Topic Subcategory

Pricing Policy & Schemes

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×